Clinical Trial Detail

NCT ID NCT03516708
Title Epacadostat (INCB024360) and Pembrolizumab Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Washington University School of Medicine
Indications

rectum cancer

Therapies

Pembrolizumab

Epacadostat

Capecitabine + Oxaliplatin

Age Groups: adult senior

No variant requirements are available.